APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biomolecule Software

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Biomolecule Software Industry Growth and Trends Forecast to 2032

1 January 2026120 pages

Choose your research edition.

Industry ResearchBiomolecule Software Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Biomolecule Software Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Biomolecule Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biomolecule Software Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Biomolecule Software Market Analysis and Forecast 2026-2032212 pages · $4,950 USD

Market perspective

According to APO Research, the global Biomolecule Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Biomolecule Software is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Biomolecule Software is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Biomolecule Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Biomolecule Software market include Hamilton Thorne, Hermes Medical Solutions, Inc, INDICAL BIOSCIENCE, lexogen, Repligen, SCC SOFT COMPUTER, Oxford Instruments, Partek, Inc. and Stilla Technologies, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Biomolecule Software market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Biomolecule Software market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Biomolecule Software market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Biomolecule Software.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Biomolecule Software market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Biomolecule Software Market by Company

Hamilton Thorne

Hermes Medical Solutions, Inc

INDICAL BIOSCIENCE

lexogen

Repligen

SCC SOFT COMPUTER

Oxford Instruments

Partek, Inc.

Stilla Technologies

Vela Diagnostics

Vittoriobasurto

SCIEX

SoftGenetics, LLC.

Benchling

BioSistemika

CapitalBio Technology

cytena GmbH

Eppendorf SE

GenomSys

Mission Bio

Multid Analyses AB

PhenoSystems SA

Progenie Molecular

Biomolecule Software Segment by Type

Windows

Linux

MacOS

Biomolecule Software Segment by Application

Hospital

Clinic

Research Center

Biomolecule Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biomolecule Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biomolecule Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biomolecule Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Biomolecule Software companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Biomolecule Software Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Biomolecule Software Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Biomolecule Software Market Share by Region (2021-2026) Table 4. Global Biomolecule Software Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Biomolecule Software Market Share by Region (2027-2032) Table 6. Global Biomolecule Software Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Biomolecule Software Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Biomolecule Software Market Size Share by Type (2021-2026) Table 9. Global Biomolecule Software Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Biomolecule Software Market Size Share Forecasted by Type (2027-2032) Table 11. North America Biomolecule Software Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Biomolecule Software Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Biomolecule Software Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Biomolecule Software Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Biomolecule Software Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Biomolecule Software Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Biomolecule Software Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Biomolecule Software Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Biomolecule Software Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Biomolecule Software Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Biomolecule Software Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Biomolecule Software Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Biomolecule Software Market Size Share by Application (2021-2026) Table 24. Global Biomolecule Software Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Biomolecule Software Market Size Share Forecasted by Application (2027-2032) Table 26. North America Biomolecule Software Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Biomolecule Software Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Biomolecule Software Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Biomolecule Software Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Biomolecule Software Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Biomolecule Software Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Biomolecule Software Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Biomolecule Software Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Biomolecule Software Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Biomolecule Software Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Biomolecule Software Industry Trends Table 37. Biomolecule Software Industry Drivers Table 38. Biomolecule Software Industry Opportunities and Challenges Table 39. Biomolecule Software Industry Restraints Table 40. Global Biomolecule Software Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Biomolecule Software Revenue Market Share by Company (2021-2026) Table 42. Global Biomolecule Software Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Biomolecule Software Key Company Headquarters & Area Served Table 44. Global Biomolecule Software Company, Product Type & Application Table 45. Global Biomolecule Software Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Biomolecule Software by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Hamilton Thorne Company Information Table 49. Hamilton Thorne Business Overview Table 50. Hamilton Thorne Biomolecule Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Hamilton Thorne Biomolecule Software Product Portfolio Table 52. Hamilton Thorne Recent Development Table 53. Hermes Medical Solutions, Inc Company Information Table 54. Hermes Medical Solutions, Inc Business Overview Table 55. Hermes Medical Solutions, Inc Biomolecule Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Hermes Medical Solutions, Inc Biomolecule Software Product Portfolio Table 57. Hermes Medical Solutions, Inc Recent Development Table 58. INDICAL BIOSCIENCE Company Information Table 59. INDICAL BIOSCIENCE Business Overview Table 60. INDICAL BIOSCIENCE Biomolecule Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. INDICAL BIOSCIENCE Biomolecule Software Product Portfolio Table 62. INDICAL BIOSCIENCE Recent Development Table 63. lexogen Company Information Table 64. lexogen Business Overview Table 65. lexogen Biomolecule Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. lexogen Biomolecule Software Product Portfolio Table 67. lexogen Recent Development Table 68. Repligen Company Information Table 69. Repligen Business Overview Table 70. Repligen Biomolecule Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Repligen Biomolecule Software Product Portfolio Table 72. Repligen Recent Development Table 73. SCC SOFT COMPUTER Company Information Table 74. SCC SOFT COMPUTER Business Overview Table 75. SCC SOFT COMPUTER Biomolecule Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. SCC SOFT COMPUTER Biomolecule Software Product Portfolio Table 77. SCC SOFT COMPUTER Recent Development Table 78. Oxford Instruments Company Information Table 79. Oxford Instruments Business Overview Table 80. Oxford Instruments Biomolecule Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Oxford Instruments Biomolecule Software Product Portfolio Table 82. Oxford Instruments Recent Development Table 83. Partek, Inc. Company Information Table 84. Partek, Inc. Business Overview Table 85. Partek, Inc. Biomolecule Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Partek, Inc. Biomolecule Software Product Portfolio Table 87. Partek, Inc. Recent Development Table 88. Stilla Technologies Company Information Table 89. Stilla Technologies Business Overview Table 90. Stilla Technologies Biomolecule Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Stilla Technologies Biomolecule Software Product Portfolio Table 92. Stilla Technologies Recent Development Table 93. Vela Diagnostics Company Information Table 94. Vela Diagnostics Business Overview Table 95. Vela Diagnostics Biomolecule Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Vela Diagnostics Biomolecule Software Product Portfolio Table 97. Vela Diagnostics Recent Development Table 98. Vittoriobasurto Company Information Table 99. Vittoriobasurto Business Overview Table 100. Vittoriobasurto Biomolecule Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Vittoriobasurto Biomolecule Software Product Portfolio Table 102. Vittoriobasurto Recent Development Table 103. SCIEX Company Information Table 104. SCIEX Business Overview Table 105. SCIEX Biomolecule Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. SCIEX Biomolecule Software Product Portfolio Table 107. SCIEX Recent Development Table 108. SoftGenetics, LLC. Company Information Table 109. SoftGenetics, LLC. Business Overview Table 110. SoftGenetics, LLC. Biomolecule Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. SoftGenetics, LLC. Biomolecule Software Product Portfolio Table 112. SoftGenetics, LLC. Recent Development Table 113. Benchling Company Information Table 114. Benchling Business Overview Table 115. Benchling Biomolecule Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Benchling Biomolecule Software Product Portfolio Table 117. Benchling Recent Development Table 118. BioSistemika Company Information Table 119. BioSistemika Business Overview Table 120. BioSistemika Biomolecule Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. BioSistemika Biomolecule Software Product Portfolio Table 122. BioSistemika Recent Development Table 123. CapitalBio Technology Company Information Table 124. CapitalBio Technology Business Overview Table 125. CapitalBio Technology Biomolecule Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. CapitalBio Technology Biomolecule Software Product Portfolio Table 127. CapitalBio Technology Recent Development Table 128. cytena GmbH Company Information Table 129. cytena GmbH Business Overview Table 130. cytena GmbH Biomolecule Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. cytena GmbH Biomolecule Software Product Portfolio Table 132. cytena GmbH Recent Development Table 133. Eppendorf SE Company Information Table 134. Eppendorf SE Business Overview Table 135. Eppendorf SE Biomolecule Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Eppendorf SE Biomolecule Software Product Portfolio Table 137. Eppendorf SE Recent Development Table 138. GenomSys Company Information Table 139. GenomSys Business Overview Table 140. GenomSys Biomolecule Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. GenomSys Biomolecule Software Product Portfolio Table 142. GenomSys Recent Development Table 143. Mission Bio Company Information Table 144. Mission Bio Business Overview Table 145. Mission Bio Biomolecule Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. Mission Bio Biomolecule Software Product Portfolio Table 147. Mission Bio Recent Development Table 148. Multid Analyses AB Company Information Table 149. Multid Analyses AB Business Overview Table 150. Multid Analyses AB Biomolecule Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 151. Multid Analyses AB Biomolecule Software Product Portfolio Table 152. Multid Analyses AB Recent Development Table 153. PhenoSystems SA Company Information Table 154. PhenoSystems SA Business Overview Table 155. PhenoSystems SA Biomolecule Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 156. PhenoSystems SA Biomolecule Software Product Portfolio Table 157. PhenoSystems SA Recent Development Table 158. Progenie Molecular Company Information Table 159. Progenie Molecular Business Overview Table 160. Progenie Molecular Biomolecule Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 161. Progenie Molecular Biomolecule Software Product Portfolio Table 162. Progenie Molecular Recent Development Table 163. North America Biomolecule Software Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. North America Biomolecule Software Market Size by Country (2021-2026) & (US$ Million) Table 165. North America Biomolecule Software Market Share by Country (2021-2026) Table 166. North America Biomolecule Software Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. North America Biomolecule Software Market Share Forecast by Country (2027-2032) Table 168. Europe Biomolecule Software Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Europe Biomolecule Software Market Size by Country (2021-2026) & (US$ Million) Table 170. Europe Biomolecule Software Market Share by Country (2021-2026) Table 171. Europe Biomolecule Software Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Europe Biomolecule Software Market Share Forecast by Country (2027-2032) Table 173. Asia-Pacific Biomolecule Software Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Asia-Pacific Biomolecule Software Market Size by Country (2021-2026) & (US$ Million) Table 175. Asia-Pacific Biomolecule Software Market Share by Country (2021-2026) Table 176. Asia-Pacific Biomolecule Software Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Asia-Pacific Biomolecule Software Market Share Forecast by Country (2027-2032) Table 178. Latin America Biomolecule Software Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Latin America Biomolecule Software Market Size by Country (2021-2026) & (US$ Million) Table 180. Latin America Biomolecule Software Market Share by Country (2021-2026) Table 181. Latin America Biomolecule Software Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Latin America Biomolecule Software Market Share Forecast by Country (2027-2032) Table 183. Middle East & Africa Biomolecule Software Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 184. Middle East & Africa Biomolecule Software Market Size by Country (2021-2026) & (US$ Million) Table 185. Middle East & Africa Biomolecule Software Market Share by Country (2021-2026) Table 186. Middle East & Africa Biomolecule Software Market Size Forecast by Country (2027-2032) & (US$ Million) Table 187. Middle East & Africa Biomolecule Software Market Share Forecast by Country (2027-2032) Table 188. Research Programs/Design for This Report Table 189. Authors List of This Report Table 190. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Biomolecule Software Product Image Figure 3. Global Biomolecule Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Biomolecule Software Market Size (2021-2032) & (US$ Million) Figure 5. Global Biomolecule Software Market Share by Region: 2025 VS 2032 Figure 6. Global Biomolecule Software Market Share by Region (2021-2032) Figure 7. North America Biomolecule Software Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Biomolecule Software Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Biomolecule Software Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Biomolecule Software Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Biomolecule Software Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Windows Image Figure 13. Global Windows Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Linux Image Figure 15. Global Linux Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. MacOS Image Figure 17. Global MacOS Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global Biomolecule Software Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global Biomolecule Software Market Share by Type 2025 VS 2032 Figure 20. North America Biomolecule Software Market Size Share by Type (2021-2032) Figure 21. Europe Biomolecule Software Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific Biomolecule Software Market Size Share by Type (2021-2032) Figure 23. Latin America Biomolecule Software Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa Biomolecule Software Market Size Share by Type (2021-2032) Figure 25. Hospital Image Figure 26. Global Hospital Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Clinic Image Figure 28. Global Clinic Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Research Center Image Figure 30. Global Research Center Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Global Biomolecule Software Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Biomolecule Software Market Share by Application 2025 VS 2032 Figure 33. North America Biomolecule Software Market Size Share by Application (2021-2032) Figure 34. Europe Biomolecule Software Market Size Share by Application (2021-2032) Figure 35. Asia-Pacific Biomolecule Software Market Size Share by Application (2021-2032) Figure 36. Latin America Biomolecule Software Market Size Share by Application (2021-2032) Figure 37. Middle East and Africa Biomolecule Software Market Size Share by Application (2021-2032) Figure 38. Global Top 5 and 10 Biomolecule Software Players Market Share by Revenue in 2025 Figure 39. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 40. North America Biomolecule Software Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 41. North America Biomolecule Software Market Share by Country: 2021 VS 2025 VS 2032 Figure 42. North America Biomolecule Software Market Share by Country (2021-2032) Figure 43. Europe Biomolecule Software Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. Europe Biomolecule Software Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Biomolecule Software Market Share by Country (2021-2032) Figure 46. Asia-Pacific Biomolecule Software Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. Asia-Pacific Biomolecule Software Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. Asia-Pacific Biomolecule Software Market Share by Country (2021-2032) Figure 49. Latin America Biomolecule Software Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Latin America Biomolecule Software Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Biomolecule Software Market Share by Country (2021-2032) Figure 52. Middle East & Africa Biomolecule Software Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Middle East & Africa Biomolecule Software Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Middle East & Africa Biomolecule Software Market Share by Country (2021-2032) Figure 55. Years Considered Figure 56. Research Process Figure 57. Key Executives Interviewed

Scope & coverage.

Types
  • Windows
  • Linux
  • MacOS
Applications
  • Hospital
  • Clinic
  • Research Center
Companies covered
  • Hamilton Thorne
  • Hermes Medical Solutions, Inc
  • INDICAL BIOSCIENCE
  • lexogen
  • Repligen
  • SCC SOFT COMPUTER
  • Oxford Instruments
  • Partek, Inc.
  • Stilla Technologies
  • Vela Diagnostics
  • Vittoriobasurto
  • SCIEX
  • SoftGenetics, LLC.
  • Benchling
  • BioSistemika
  • CapitalBio Technology
  • cytena GmbH
  • Eppendorf SE
  • GenomSys
  • Mission Bio
  • Multid Analyses AB
  • PhenoSystems SA
  • Progenie Molecular

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Biomolecule Software Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Biomolecule Software Market Size by Region (2021-2032)
  5. 1.4.1 Global Biomolecule Software Market Size by Region (2021-2026)
  6. 1.4.2 Global Biomolecule Software Market Size by Region (2027-2032)
  7. 1.5 Key Regions Biomolecule Software Market Size (2021-2032)
  8. 1.5.1 North America Biomolecule Software Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Biomolecule Software Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Biomolecule Software Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Biomolecule Software Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Biomolecule Software Market Size Growth Rate (2021-2032)
2 Biomolecule Software Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Windows
  3. 2.1.2 Linux
  4. 2.1.3 MacOS
  5. 2.2 Global Biomolecule Software Market Size by Type
  6. 2.2.1 Global Biomolecule Software Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global Biomolecule Software Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global Biomolecule Software Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global Biomolecule Software Market Size by Regions
  10. 2.3.1 North America Biomolecule Software Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe Biomolecule Software Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific Biomolecule Software Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America Biomolecule Software Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa Biomolecule Software Market Size Breakdown by Type (2021-2026)
3 Biomolecule Software Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital
  3. 3.1.2 Clinic
  4. 3.1.3 Research Center
  5. 3.2 Global Biomolecule Software Market Size by Application
  6. 3.2.1 Global Biomolecule Software Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Biomolecule Software Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Biomolecule Software Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Biomolecule Software Market Size by Regions
  10. 3.3.1 North America Biomolecule Software Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Biomolecule Software Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Biomolecule Software Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Biomolecule Software Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Biomolecule Software Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Biomolecule Software Industry Trends
  2. 4.2 Biomolecule Software Industry Drivers
  3. 4.3 Biomolecule Software Industry Opportunities and Challenges
  4. 4.4 Biomolecule Software Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Biomolecule Software Revenue (2021-2026)
  2. 5.2 Global Biomolecule Software Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Biomolecule Software Key Company Headquarters & Area Served
  4. 5.4 Global Biomolecule Software Company, Product Type & Application
  5. 5.5 Global Biomolecule Software Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Biomolecule Software Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Biomolecule Software Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Biomolecule Software Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Hamilton Thorne
  2. 6.1.1 Hamilton Thorne Company Information
  3. 6.1.2 Hamilton Thorne Business Overview
  4. 6.1.3 Hamilton Thorne Biomolecule Software Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Hamilton Thorne Biomolecule Software Product Portfolio
  6. 6.1.5 Hamilton Thorne Recent Developments
  7. 6.2 Hermes Medical Solutions, Inc
  8. 6.2.1 Hermes Medical Solutions, Inc Company Information
  9. 6.2.2 Hermes Medical Solutions, Inc Business Overview
  10. 6.2.3 Hermes Medical Solutions, Inc Biomolecule Software Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Hermes Medical Solutions, Inc Biomolecule Software Product Portfolio
  12. 6.2.5 Hermes Medical Solutions, Inc Recent Developments
  13. 6.3 INDICAL BIOSCIENCE
  14. 6.3.1 INDICAL BIOSCIENCE Company Information
  15. 6.3.2 INDICAL BIOSCIENCE Business Overview
  16. 6.3.3 INDICAL BIOSCIENCE Biomolecule Software Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 INDICAL BIOSCIENCE Biomolecule Software Product Portfolio
  18. 6.3.5 INDICAL BIOSCIENCE Recent Developments
  19. 6.4 lexogen
  20. 6.4.1 lexogen Company Information
  21. 6.4.2 lexogen Business Overview
  22. 6.4.3 lexogen Biomolecule Software Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 lexogen Biomolecule Software Product Portfolio
  24. 6.4.5 lexogen Recent Developments
  25. 6.5 Repligen
  26. 6.5.1 Repligen Company Information
  27. 6.5.2 Repligen Business Overview
  28. 6.5.3 Repligen Biomolecule Software Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Repligen Biomolecule Software Product Portfolio
  30. 6.5.5 Repligen Recent Developments
  31. 6.6 SCC SOFT COMPUTER
  32. 6.6.1 SCC SOFT COMPUTER Company Information
  33. 6.6.2 SCC SOFT COMPUTER Business Overview
  34. 6.6.3 SCC SOFT COMPUTER Biomolecule Software Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 SCC SOFT COMPUTER Biomolecule Software Product Portfolio
  36. 6.6.5 SCC SOFT COMPUTER Recent Developments
  37. 6.7 Oxford Instruments
  38. 6.7.1 Oxford Instruments Company Information
  39. 6.7.2 Oxford Instruments Business Overview
  40. 6.7.3 Oxford Instruments Biomolecule Software Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Oxford Instruments Biomolecule Software Product Portfolio
  42. 6.7.5 Oxford Instruments Recent Developments
  43. 6.8 Partek, Inc.
  44. 6.8.1 Partek, Inc. Company Information
  45. 6.8.2 Partek, Inc. Business Overview
  46. 6.8.3 Partek, Inc. Biomolecule Software Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Partek, Inc. Biomolecule Software Product Portfolio
  48. 6.8.5 Partek, Inc. Recent Developments
  49. 6.9 Stilla Technologies
  50. 6.9.1 Stilla Technologies Company Information
  51. 6.9.2 Stilla Technologies Business Overview
  52. 6.9.3 Stilla Technologies Biomolecule Software Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Stilla Technologies Biomolecule Software Product Portfolio
  54. 6.9.5 Stilla Technologies Recent Developments
  55. 6.10 Vela Diagnostics
  56. 6.10.1 Vela Diagnostics Company Information
  57. 6.10.2 Vela Diagnostics Business Overview
  58. 6.10.3 Vela Diagnostics Biomolecule Software Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Vela Diagnostics Biomolecule Software Product Portfolio
  60. 6.10.5 Vela Diagnostics Recent Developments
  61. 6.11 Vittoriobasurto
  62. 6.11.1 Vittoriobasurto Company Information
  63. 6.11.2 Vittoriobasurto Business Overview
  64. 6.11.3 Vittoriobasurto Biomolecule Software Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Vittoriobasurto Biomolecule Software Product Portfolio
  66. 6.11.5 Vittoriobasurto Recent Developments
  67. 6.12 SCIEX
  68. 6.12.1 SCIEX Company Information
  69. 6.12.2 SCIEX Business Overview
  70. 6.12.3 SCIEX Biomolecule Software Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 SCIEX Biomolecule Software Product Portfolio
  72. 6.12.5 SCIEX Recent Developments
  73. 6.13 SoftGenetics, LLC.
  74. 6.13.1 SoftGenetics, LLC. Company Information
  75. 6.13.2 SoftGenetics, LLC. Business Overview
  76. 6.13.3 SoftGenetics, LLC. Biomolecule Software Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 SoftGenetics, LLC. Biomolecule Software Product Portfolio
  78. 6.13.5 SoftGenetics, LLC. Recent Developments
  79. 6.14 Benchling
  80. 6.14.1 Benchling Company Information
  81. 6.14.2 Benchling Business Overview
  82. 6.14.3 Benchling Biomolecule Software Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Benchling Biomolecule Software Product Portfolio
  84. 6.14.5 Benchling Recent Developments
  85. 6.15 BioSistemika
  86. 6.15.1 BioSistemika Company Information
  87. 6.15.2 BioSistemika Business Overview
  88. 6.15.3 BioSistemika Biomolecule Software Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 BioSistemika Biomolecule Software Product Portfolio
  90. 6.15.5 BioSistemika Recent Developments
  91. 6.16 CapitalBio Technology
  92. 6.16.1 CapitalBio Technology Company Information
  93. 6.16.2 CapitalBio Technology Business Overview
  94. 6.16.3 CapitalBio Technology Biomolecule Software Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 CapitalBio Technology Biomolecule Software Product Portfolio
  96. 6.16.5 CapitalBio Technology Recent Developments
  97. 6.17 cytena GmbH
  98. 6.17.1 cytena GmbH Company Information
  99. 6.17.2 cytena GmbH Business Overview
  100. 6.17.3 cytena GmbH Biomolecule Software Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 cytena GmbH Biomolecule Software Product Portfolio
  102. 6.17.5 cytena GmbH Recent Developments
  103. 6.18 Eppendorf SE
  104. 6.18.1 Eppendorf SE Company Information
  105. 6.18.2 Eppendorf SE Business Overview
  106. 6.18.3 Eppendorf SE Biomolecule Software Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Eppendorf SE Biomolecule Software Product Portfolio
  108. 6.18.5 Eppendorf SE Recent Developments
  109. 6.19 GenomSys
  110. 6.19.1 GenomSys Company Information
  111. 6.19.2 GenomSys Business Overview
  112. 6.19.3 GenomSys Biomolecule Software Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 GenomSys Biomolecule Software Product Portfolio
  114. 6.19.5 GenomSys Recent Developments
  115. 6.20 Mission Bio
  116. 6.20.1 Mission Bio Company Information
  117. 6.20.2 Mission Bio Business Overview
  118. 6.20.3 Mission Bio Biomolecule Software Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 Mission Bio Biomolecule Software Product Portfolio
  120. 6.20.5 Mission Bio Recent Developments
  121. 6.21 Multid Analyses AB
  122. 6.21.1 Multid Analyses AB Company Information
  123. 6.21.2 Multid Analyses AB Business Overview
  124. 6.21.3 Multid Analyses AB Biomolecule Software Revenue, Global Share and Gross Margin (2021-2026)
  125. 6.21.4 Multid Analyses AB Biomolecule Software Product Portfolio
  126. 6.21.5 Multid Analyses AB Recent Developments
  127. 6.22 PhenoSystems SA
  128. 6.22.1 PhenoSystems SA Company Information
  129. 6.22.2 PhenoSystems SA Business Overview
  130. 6.22.3 PhenoSystems SA Biomolecule Software Revenue, Global Share and Gross Margin (2021-2026)
  131. 6.22.4 PhenoSystems SA Biomolecule Software Product Portfolio
  132. 6.22.5 PhenoSystems SA Recent Developments
  133. 6.23 Progenie Molecular
  134. 6.23.1 Progenie Molecular Company Information
  135. 6.23.2 Progenie Molecular Business Overview
  136. 6.23.3 Progenie Molecular Biomolecule Software Revenue, Global Share and Gross Margin (2021-2026)
  137. 6.23.4 Progenie Molecular Biomolecule Software Product Portfolio
  138. 6.23.5 Progenie Molecular Recent Developments
7 North America
  1. 7.1 North America Biomolecule Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Biomolecule Software Market Size by Country (2021-2026)
  3. 7.3 North America Biomolecule Software Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Biomolecule Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Biomolecule Software Market Size by Country (2021-2026)
  3. 8.3 Europe Biomolecule Software Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Biomolecule Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Biomolecule Software Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Biomolecule Software Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Biomolecule Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Biomolecule Software Market Size by Country (2021-2026)
  3. 10.3 South America Biomolecule Software Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Biomolecule Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Biomolecule Software Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Biomolecule Software Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst